Navigation Links
Oramed Pharmaceuticals Announces Successful Phase 1 Clinical Trial Results for EnteraBio
Date:9/27/2011

enced management team with more than 50 years of combined drug development experience.

For more information, please visit http://www.enterabio.com

SafeHarbor Statement

Some of the statements contained in this press release are forward-looking statements which involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward looking statements, including the risks and uncertainties related to the progress, timing, cost, and results of clinical trials and product development programs; difficulties or delays in obtaining regulatory approval for our product candidates; competition from other pharmaceutical or biotechnology companies; and the Company's ability to obtain additional funding required to conduct its research, development and commercialization activities. Please refer to the Company's filings with the Securities and Exchange Commission for a comprehensive list of risk factors that could cause actual results, performance or achievements of the Company to differ materially from those expressed or implied in such forward looking statements. The Company undertakes no obligation to update or revise any forward-looking statements.

Company and Investor Relations Contacts:
Oramed Pharmaceuticals
Tara Horn
Office: +1-646-240-4193
Cell: +972-54-334-4318
Email: tara@oramed.com



'/>"/>
SOURCE Oramed Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Oramed Pharmaceuticals Chosen to Present at the 8th Annual Israel Strategic Partner and Venture Conference on September 22, 2011
2. Oramed Pharmaceuticals to Present at Rodman & Renshaw 13th Annual Global Investment Conference
3. Oramed Pharmaceuticals Announces Successful Results of a Novel Exploratory Clinical Study of its Flagship Oral Insulin Capsule
4. Oramed Pharmaceuticals and sanofi-aventis Enter Into an Agreement for the Insulin Supply of Orameds Oral Insulin Capsules
5. Oramed Pharmaceuticals to Present at the 70th Scientific Sessions of the American Diabetes Association
6. Oramed Pharmaceuticals Forms Joint Venture - Launches Entera Bio Ltd.
7. Oramed Pharmaceuticals Expands Scientific Advisory Board With the Appointment of John Amatruda, M.D.
8. Oramed Pharmaceuticals Announces Filing of Two Registration Statements
9. Oramed Pharmaceuticals was Chosen to Present Results of a GLP-1 Analog Oral Administration Study at the Diabetes Technology Societys Ninth Annual Meeting (November 5-7, 2009; San Francisco, CA)
10. Orameds Chief Scientific Officer, Miriam Kidron, Ph.D., Chosen to Lecture at the 2009 British Pharmaceutical Conference in Manchester, England
11. Oramed Pharmaceuticals to Present at the 8th National Life Science & Technology Week ILSI -BIOMED Conference, Israel 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... , Jan. 23, 2015  A new analysis of Centers ... 2015 enrollment data shows that 81 percent of seniors ... and extra discounts at certain pharmacies. The findings were ... pharmacy plans are now the foundation of Medicare Part ...
(Date:1/23/2015)... Jan. 23, 2015 /PRNewswire/-- Harwood Feffer LLP ( www.hfesq.com ) ... of Advaxis, Inc. ("Advaxis" or the "Company") (NASDAQ: ... its fiduciary duties to shareholders. On January ... website reporting that Advaxis had misrepresented the clinical data ...
(Date:1/23/2015)... , Jan. 23, 2015  Lixte Biotechnology Holdings, Inc. (OTCQB: LIXT), ... I trial of Lixte,s lead compound, LB‑100, is being conducted, ... John S. Kovach , M.D., the founder and President ... be completed at a single site. Accrual of patients, however, ...
Breaking Medicine Technology:New Analysis: 81 Percent of Medicare Part D Seniors Choose "Preferred Pharmacy" Plans in 2015 2Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3
... 29 Zeltiq Aesthetics, a science-based medical device company dedicated ... unwanted fat tissue, has announced the appointment of Gordie ... Mitch Levinson, the founder of Zeltiq Aesthetics, who served as ... a member of the Board of Directors since 2006. ...
... Misonix, Inc. (Nasdaq: MSON ), a developer of ... is used for the ablation of tumors and worldwide ... release fourth quarter and fiscal year ended June 30, ... Michael A. McManus, President and Chief Executive Officer ...
Cached Medicine Technology:Zeltiq Aesthetics Names Gordie Nye to Serve as New CEO 2Zeltiq Aesthetics Names Gordie Nye to Serve as New CEO 3Misonix Schedules Fourth Quarter and Fiscal Year 2009 Financial Results Conference Call; October 1, 2009 at 4:30 p.m. Eastern 2
(Date:1/22/2015)... (PRWEB) January 22, 2015 IsoComforter, Inc. has ... machine with patented IsoTube design to treat specific body parts ... the most progressive and easy to use patented cold therapy ... and sports related orthopedic and muscle injuries. IsoComforter has ...
(Date:1/22/2015)... 2015 Payday lending practices in four ... cause financial distress to the states that permit them, ... University’s Center on Race and Wealth. , While they ... payday loans at the same time substantially depress economic ...
(Date:1/22/2015)... January 22, 2015 As interest in the ... care gains momentum worldwide, Rev. Eric J. Hall , ... Network (HCCN), will be the keynote speaker on January ... Israel’s public health system. , The conference, “Hope and Resilience: ...
(Date:1/22/2015)... a new blog post presenting a list of vehicles that cannot ... Some types of vehicles cannot be covered under an ordinary auto ... see if their vehicle qualifies for auto insurance coverage. , ... that cannot be covered by a plan. Clients have little options ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Step into ... at the Science Museum of Virginia. Wicked Plants, the ... Wicked Plants unearths 75 poisonous, carnivorous and diabolical plants ... each room to uncover the biochemical, physical and neurological ...
Breaking Medicine News(10 mins):Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3Health News:Some Vehicles Cannot Be Covered By An Auto Insurance Policy! 2Health News:Wicked Plants are taking over the Science Museum of Virginia 2
... a person loses a large amount of blood the consequences ... have to be kept available in hospitals and blood banks. ... villages and conducting blood donation sessions in a laboratory bus. ... taken contain pathogens, including HIV, hepatitis and syphilis. As these ...
... 1 , Watch4net,s Testimonial , ... healthcare providers in terms of limited personnel and budget ... Health. An industry typically marked by growth is starting ... level executives are being tasked to run leaner organizations ...
... Two-thirds of women with psoriasis say the disease ... PORTLAND, Ore., Oct. 1 Women with psoriasis and ... suffer from the emotional and psychological effects of the ... Psoriasis Foundation today. , Psoriasis is the most prevalent ...
... ... for life science careers and information, unveiled the eleventh edition of the Biotech Beach™ ... ... resource for life science careers and information, unveiled the eleventh edition of the Biotech ...
... ... University Edwardsville School of Pharmacy has launched a new Web site: www.pharmacypainsummit.com , ... pharmacy. , ... IL (PRWEB) October 1, 2009 -- The Southern Illinois University Edwardsville School of ...
... Oct.1 issue of the journal Sleep shows that ... consistently report that their sleep is shorter and poorer. ... all of the subjective measures, including a 13.2 minute shorter ... (SOL), and a 4.2 percent lower sleep efficiency. When sleep ...
Cached Medicine News:Health News:Blood diagnosis -- chip-based and mobile 2Health News:Clarian Health Selects Watch4net for Performance Reporting and Automatic Analysis 2Health News:Largest Survey of Its Kind Finds the Psychological and Social Effects of Psoriasis Greater for Women 2Health News:Largest Survey of Its Kind Finds the Psychological and Social Effects of Psoriasis Greater for Women 3Health News:BioSpace Launches the 2010 Biotech Beach Hotbed Campaign 2Health News:SIUE School of Pharmacy Launches Collaborative Site for Pain, Palliative Care Pharmacy 2Health News:SIUE School of Pharmacy Launches Collaborative Site for Pain, Palliative Care Pharmacy 3Health News:Study shows that elderly women sleep better than they think, men sleep worse 2
... a fully threaded 2.4 mm diameter titanium suture ... predrilling using either a powered handpiece or manually ... This implant is ideal for Bankart and SLAP ... with very high pull-out strengths. FASTak anchors are ...
... one step fixation of soft tissue to bone. ... cuff repair in one simple insertion maneuver. The ... of 5 mm and a small 2 mm ... hold a thin, bioabsorbable PLLA disc 5 mm ...
... Needles are ideal for arthroscopic suture passing ... are preloaded on one end of each ... As the anchor is being inserted, ensure ... tissue before removing the handle to ensure ...
... a 3 mm x 14 mm bioabsorbable threaded ... shoulder, knee, elbow and ankle. The exclusive braided ... of the anchor and provides superior resistance to ... unique eyelet design allows the attached suture to ...
Medicine Products: